Showing posts with label AMLN. Show all posts
Showing posts with label AMLN. Show all posts

Tuesday, May 15, 2012

Tuesday’s biggest gaining and declining stocks

Tuesday’s biggest gaining and declining stocksShawshank, VA 5/15/12 (StreetBeat) -- Here are some of the biggest gaining and declining stocks in U.S. market trading on Tuesday:

Gainers

Amylin Pharmaceuticals Inc. (Nasdaq: AMLN +4.85%) shares tacked on 5%. The company said in a filing late Monday that one of its directors had bought 18,000 shares of the firm’s stock.

Dick’s Sporting Goods (NYSE: DKS +6.33%) rose 8% after reporting a 53% jump in profit that breezed past Wall Street expectations.

Groupon Inc. (Nasdaq: GRPN +15.89%) shares jumped 19% after the company reported better-than-expected revenue for its first quarter on Monday, along with a strong forecast.

Decliners

Shares of Avon Products Inc. (NYSE: AVP -10.54%) fell 12% after Coty Inc. pulled its more than $10 billion bid for the beauty-products firm. In a letter to Avon’s board, Coty said that it had wanted to do a friendly deal, but “your total lack of engagement with us leads us to believe that you remain reluctant to explore a friendly, negotiated, combination on a reasonable timetable.”

Home Depot (NYSE: HD -2.07%) was off about 5% after its quarterly sales missed expectations and its outlook also came in slightly short.

Summer Infant Inc. (Nasdaq: SUMR -25.36%) shares retreated by 26%. The company reported flat quarterly profit and declining margins on Monday afternoon.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Wednesday, March 28, 2012

Bristol-Myers (NYSE: BMY) offers $3.5 billion for Amylin (Nasdaq: AMLN) -Bloomberg

Bristol-Myers (NYSE: BMY) offers $3.5 billion for Amylin (Nasdaq: AMLN) -BloombergTallahassee, FL 3/28/12 (StreetBeat) -- Shares of Amylin Pharmaceuticals Inc (Nasdaq: AMLN) rose as much as 51 percent on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb Co (NYSE: BMY).

Bristol-Myers proposed an acquisition at $22 a share in a letter to Amylin, which the board turned down last month, according to Bloomberg, which cited two people with knowledge of the matter.

Bloomberg said Bristol-Myers hasn't approached Amylin since the rejection.

Amylin's shares rose 41 percent to $21.65 in hectic early trading on Nasdaq. Earlier in the session they rose to a year-high $23.26.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly